Stocks and Investing Stocks and Investing
Wed, October 23, 2019
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (WMB) at Strong Buy with Decreased Target to $32 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Randy Giveans Upgraded (TNK) to Strong Buy and Increased Target to $20 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Lisa Gill Downgraded (WBA) to Hold and Decreased Target to $63 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Doug Anmuth Upgraded (SNAP) to Buy on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Ross Sandler Maintained (SNAP) at Buy with Increased Target to $20 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Laura Martin Upgraded (SNAP) to Hold on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Pachter Maintained (SNAP) at Hold and Held Target at $15 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Stephen Ju Maintained (SNAP) at Buy with Increased Target to $22 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Ryan MacDonald Initiated (VRNT) at Strong Buy and Held Target at $53 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (SUN) at Buy with Increased Target to $35 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Jason McCarthy Upgraded (TTNP) to Strong Buy and Held Target at $600 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Edward Snyder Downgraded (TXN) to Hold on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
William Stein Maintained (TXN) at Hold with Decreased Target to $122 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Joseph Moore Maintained (TXN) at Hold with Decreased Target to $109 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Vijay Rakesh Maintained (TXN) at Hold with Decreased Target to $113 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Ross Seymore Maintained (TXN) at Hold with Decreased Target to $115 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Vivek Arya Reiterated (TXN) at Strong Buy with Decreased Target to $140 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Timothy Arcuri Maintained (TXN) at Strong Sell with Increased Target to $110 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Joshua Shanker Upgraded (TRV) to Hold and Held Target at $140 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Kai Pan Maintained (TRV) at Sell with Decreased Target to $125 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Elyse Greenspan Maintained (TRV) at Hold with Decreased Target to $136 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Toni Kaplan Maintained (TRU) at Hold with Increased Target to $84 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Kevin Mcveigh Maintained (TRU) at Strong Buy with Increased Target to $85 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Chris LaFemina Upgraded (ARCH) to Strong Buy and Increased Target to $100 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Thomas Smith Upgraded (ACRS) to Buy on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Rajat Gupta Maintained (ABG) at Hold with Decreased Target to $99 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Increased Target to $72 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Adnan Butt Upgraded (BIIB) to Strong Buy on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Andrew Fein Reiterated (BIIB) at Strong Buy with Increased Target to $335 on, Oct 23rd, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $262 on, Oct 23rd, 2019

Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $262 on, Oct 23rd, 2019


Published on 2024-10-26 17:13:51 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Sell with Increased Target from $212 to $262 on, Oct 23rd, 2019.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019

Contributing Sources